Michael Tauber

Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics

Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics. Since 2002, he has worked in various areas of pharmaceutical development including early and late stage development, pre-formulation and formulation for solid oral development, formulation and scale up of spray dried engineered particles for inhalation delivery and management of CMC related activities supporting the development and commercialization of Inbrija®.

Additionally Michael has served at the solid state chemistry technical lead on numerous projects over the years and had established solid state labs as well as instructed many peers on this topic. More recently he has managed all aspects of the extractables and leachables program for Inbrija® through NDA/MAA approval. Michael holds a B.S in Chemistry from UMass Boston and an M.S. in Chemistry from Northeastern University.

Michael_Tauber_Acorda_BioTech_Pharma_Summit 2021_gallery

Title: “ARCUS®: Engineered Spray Dried Particles for Inhalation Delivery”

This presentation will also be delivered by:

Kevin Kee, Executive Director of Analytical Development and Quality Control at Acorda Therapeutics.